Lavonne M. Patton, PhD, is Director, Regulatory Affairs and Product Development for Cardinal Health Regulatory Sciences.
Dr. Patton is responsible for managerial and nonclinical technical aspects of the business, providing nonclinical and regulatory support for the development of new and existing programs.
Dr. Patton has more than 29 years of experience in the pharmaceutical industry, focusing in the areas of nonclinical drug development and the development of scientific and regulatory strategies for pharmaceutical drug, biologic and medical device development programs. Prior to joining Cardinal Health in 2004, Dr. Patton held senior research positions with Quintiles and spent 18 years in management positions in nonclinical development and regulatory affairs with Hoechst Marion Roussel Inc. (formerly Marion Merrell Dow and Marion Laboratories).
She has authored and co-authored research articles on drug development and drug repurposing and has been an invited speaker at the University of Kansas School of Pharmacy. Dr. Patton has led and participated in numerous meetings with FDA across different therapeutic areas and indications and has experience with Health Canada.
Dr. Patton’s therapeutic experience includes oncology, antiviral, special pathogen, endocrinology, urology, dermatology, central nervous system, cardiovascular and device programs.
Dr. Patton received a master’s degree and doctorate in pharmacology and toxicology from the University of Kansas.